LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 92

Search options

  1. Article ; Online: Assessing the genetic relationship between gastroesophageal reflux disease and chronic respiratory diseases: a mendelian randomization study.

    Cheng, Xiaoxue / Shi, Jiang / Zhang, Ding / Li, Caichen / Xu, Haoxiang / He, Jianxing / Liang, Wenhua

    BMC pulmonary medicine

    2023  Volume 23, Issue 1, Page(s) 243

    Abstract: Background: Previous observational studies have found an association between gastroesophageal reflux disease (GERD) and chronic respiratory diseases, but it remains uncertain whether GERD causally influences these diseases. In this study, we aimed to ... ...

    Abstract Background: Previous observational studies have found an association between gastroesophageal reflux disease (GERD) and chronic respiratory diseases, but it remains uncertain whether GERD causally influences these diseases. In this study, we aimed to estimate the causal associations between GERD and 5 chronic respiratory diseases.
    Methods: 88 GERD-associated single nucleotide polymorphisms (SNPs) identified by the latest genome-wide association study were included as instrumental variables. Individual-level genetic summary data of participants were obtained from corresponding studies and the FinnGen consortium. We applied the inverse-variance weighted method to estimate the causality between genetically predicted GERD and 5 chronic respiratory diseases. Furthermore, the associations between GERD and common risk factors were investigated, and mediation analyses were conducted using multivariable MR. Various sensitivity analyses were also performed to verify the robustness of the findings.
    Results: Our study demonstrated that genetically predicted GERD was causally associated with an increased risk of asthma (OR 1.39, 95%CI 1.25-1.56, P < 0.001), idiopathic pulmonary fibrosis (IPF) (OR 1.43, 95%CI 1.05-1.95, P = 0.022), chronic obstructive disease (COPD) (OR 1.64, 95%CI 1.41-1.93, P < 0.001), chronic bronchitis (OR 1.77, 95%CI 1.15-2.74, P = 0.009), while no correlation was observed for bronchiectasis (OR 0.93, 95%CI 0.68-1.27, P = 0.645). Additionally, GERD was associated with 12 common risk factors for chronic respiratory diseases. Nevertheless, no significant mediators were discovered.
    Conclusions: Our study suggested that GERD was a causal factor in the development of asthma, IPF, COPD and chronic bronchitis, indicating that GERD-associated micro-aspiration of gastric contents process might play a role in the development of pulmonary fibrosis in these diseases.
    MeSH term(s) Humans ; Bronchitis, Chronic/complications ; Genome-Wide Association Study ; Mendelian Randomization Analysis ; Gastroesophageal Reflux/complications ; Gastroesophageal Reflux/genetics ; Asthma/epidemiology ; Asthma/genetics ; Asthma/complications ; Respiration Disorders/complications ; Idiopathic Pulmonary Fibrosis
    Language English
    Publishing date 2023-07-04
    Publishing country England
    Document type Journal Article
    ZDB-ID 2059871-3
    ISSN 1471-2466 ; 1471-2466
    ISSN (online) 1471-2466
    ISSN 1471-2466
    DOI 10.1186/s12890-023-02502-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Novel evidence revealed genetic association between COVID-19 infection, severity and endometrial cancer.

    Wu, Xiangrong / Peng, Haoxin / Xiong, Shan / Li, Caichen / Zhong, Ran / He, Jianxing / Liang, Wenhua

    The Journal of infection

    2022  Volume 85, Issue 1, Page(s) e1–e3

    MeSH term(s) COVID-19 ; Endometrial Neoplasms/genetics ; Female ; Genetic Predisposition to Disease ; Humans ; Polymorphism, Single Nucleotide
    Language English
    Publishing date 2022-05-10
    Publishing country England
    Document type Letter ; Comment
    ZDB-ID 424417-5
    ISSN 1532-2742 ; 0163-4453
    ISSN (online) 1532-2742
    ISSN 0163-4453
    DOI 10.1016/j.jinf.2022.05.005
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Gout and susceptibility and severity of COVID-19: A bidirectional Mendelian randomization analysis.

    Peng, Haoxin / Wu, Xiangrong / Xiong, Shan / Li, Caichen / Zhong, Ran / He, Jianxing / Liang, Wenhua

    The Journal of infection

    2022  Volume 85, Issue 3, Page(s) e59–e61

    MeSH term(s) COVID-19 ; Gout ; Humans ; Mendelian Randomization Analysis ; Polymorphism, Single Nucleotide
    Language English
    Publishing date 2022-06-18
    Publishing country England
    Document type Letter ; Research Support, Non-U.S. Gov't
    ZDB-ID 424417-5
    ISSN 1532-2742 ; 0163-4453
    ISSN (online) 1532-2742
    ISSN 0163-4453
    DOI 10.1016/j.jinf.2022.05.042
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Cost-Effectiveness Analysis of Risk Factor-Based Lung Cancer Screening Program by Low-Dose Computer Tomography in Current Smokers in China.

    Zhang, Tiantian / Chen, Xudong / Li, Caichen / Wen, Xiaoqin / Lin, Tengfei / Huang, Jiaxing / He, Jianxing / Zhong, Nanshan / Jiang, Jie / Liang, Wenhua

    Cancers

    2023  Volume 15, Issue 18

    Abstract: Although the effectiveness of lung cancer screening by low-dose computed tomography (LDCT) could be shown in China, there could be variation in the evidence concerning the economic impact. Our study explores the cost-effectiveness of lung cancer ... ...

    Abstract Although the effectiveness of lung cancer screening by low-dose computed tomography (LDCT) could be shown in China, there could be variation in the evidence concerning the economic impact. Our study explores the cost-effectiveness of lung cancer screening and optimizes the best definition of a high-risk population. A Markov model consisting of the natural history and post-diagnosis states was constructed to estimate the costs and quality-adjusted life years (QALYs) of LDCT screening compared with no screening. A total of 36 distinct risk factor-based screening strategies were assessed by incorporating starting ages of 40, 45, 50, 55, 60 and 65 years, stopping ages of 69, 74 and 79 years as well as smoking eligibility criteria. Screening data came from community-based mass screening with LDCT for lung cancer in Guangzhou. Compared with no screening, all screening scenarios led to incremental costs and QALYs. When the willingness-to-pay (WTP) threshold was USD37,653, three times the gross domestic product (GDP) per capita in China, six of nine strategies on the efficiency frontier may be cost-effective. Annual screening between 55 and 79 years of age for those who smoked more than 20 pack-years, which yielded an incremental cost-effectiveness ratio (ICER) of USD35,000.00 per QALY gained, was considered optimal. In sensitivity analyses, the result was stable in most cases. The trends of the results are roughly the same in scenario analyses. According to the WTP threshold of different regions, the optimal screening strategies were annual screening for those who smoked more than 20 pack-years, between 50 and 79 years of age in Zhejiang province, 55-79 years in Guangdong province and 65-74 years in Yunnan province. However, annual screening was unlikely to be cost-effective in Heilongjiang province under our modelling assumptions, indicating that tailored screening policies should be made regionally according to the local epidemiological and economic situation.
    Language English
    Publishing date 2023-09-06
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2527080-1
    ISSN 2072-6694
    ISSN 2072-6694
    DOI 10.3390/cancers15184445
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Molecular and immune characterization of Chinese early-stage non-squamous non-small cell lung cancer: a multi-omics cohort study.

    Peng, Haoxin / Wu, Xiangrong / Cui, Xiaoli / Liu, Shaopeng / Liang, Yueting / Cai, Xiuyu / Shi, Mengping / Zhong, Ran / Li, Caichen / Liu, Jun / Wu, Dongfang / Gao, Zhibo / Lu, Xu / Luo, Haitao / He, Jianxing / Liang, Wenhua

    Translational lung cancer research

    2024  Volume 13, Issue 4, Page(s) 763–784

    Abstract: Background: Albeit considered with superior survival, around 30% of the early-stage non-squamous non-small cell lung cancer (Ns-NSCLC) patients relapse within 5 years, suggesting unique biology. However, the biological characteristics of early-stage Ns- ... ...

    Abstract Background: Albeit considered with superior survival, around 30% of the early-stage non-squamous non-small cell lung cancer (Ns-NSCLC) patients relapse within 5 years, suggesting unique biology. However, the biological characteristics of early-stage Ns-NSCLC, especially in the Chinese population, are still unclear.
    Methods: Multi-omics interrogation of early-stage Ns-NSCLC (stage I-III), paired blood samples and normal lung tissues (n=76) by whole-exome sequencing (WES), RNA sequencing, and T-cell receptor (TCR) sequencing were conducted.
    Results: An average of 128 exonic mutations were identified, and the most frequently mutant gene was
    Conclusions: This study comprehensively profiled the genomic, transcriptomic, and TCR repertoire spectrums of Chinese early-stage Ns-NSCLC, shedding light on biological underpinnings and candidate biomarkers for prognosis development.
    Language English
    Publishing date 2024-04-25
    Publishing country China
    Document type Journal Article
    ZDB-ID 2754335-3
    ISSN 2226-4477 ; 2218-6751
    ISSN (online) 2226-4477
    ISSN 2218-6751
    DOI 10.21037/tlcr-23-800
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Association of birth weight with cancer risk: a dose-response meta-analysis and Mendelian randomization study.

    Chen, Chao / Chen, Xiaoying / Wu, Donghong / Wang, Huiting / Wang, Chuqiao / Shen, Jieni / An, Yiran / Zhong, Ran / Li, Caichen / Liang, Wenhua

    Journal of cancer research and clinical oncology

    2022  Volume 149, Issue 7, Page(s) 3925–3935

    Abstract: Background: Several articles have shown that birth weight is associated with the risk of many types of cancers. However, the results are inconsistent, and whether the relationship has a causal effect remains unknown.: Methods: We searched the PubMed ... ...

    Abstract Background: Several articles have shown that birth weight is associated with the risk of many types of cancers. However, the results are inconsistent, and whether the relationship has a causal effect remains unknown.
    Methods: We searched the PubMed and Embase libraries up to March 2021 and selected observational studies reporting the relationship between birth weight and adult-onset cancer risk. Dose-response meta-analysis and two-sample Mendelian randomization (MR) analysis were used to estimate the effect.
    Result: In our dose-response meta-analysis, six cancers from 46 studies were found to have significant associations with birth weight. (Ovarian cancer: RR: 1.21, 95% CI 1.01-1.44; breast cancer: RR: 1.12, 95% CI 1.08-1.16; colorectal cancer: RR: 1.20, 95% CI 1.01-1.43; endometrial cancer: RR: 0.85, 95% CI 0.78-0.93; prostate cancer: RR: 1.27, 95% CI 1.01-1.61; testicular cancer: RR: 1.21, 95% CI 1.03-1.43). As birth weight increased, the slope of the dose-response curve of breast cancer increased continuously, and the curve of testicular cancer was U-shaped. In the MR study, seven cancers were included. Only invasive mucinous ovarian cancer was found to have a causal effect on birth weight (OR: 0.62; 95% CI 0.39-0.97), while other cancers did not.
    Conclusions: Our findings suggest that birth weight are unlikely to have a casual effect on risk of cancers via the MR analysis, although the dose-response meta-analysis shows that there is a nonlinear relationship between birth weight and breast cancer and testicular cancer. More relevant researches are needed to further investigate their effect.
    MeSH term(s) Male ; Adult ; Female ; Humans ; Birth Weight ; Testicular Neoplasms ; Mendelian Randomization Analysis ; Breast Neoplasms ; Ovarian Neoplasms ; Genome-Wide Association Study ; Polymorphism, Single Nucleotide
    Language English
    Publishing date 2022-08-27
    Publishing country Germany
    Document type Meta-Analysis ; Journal Article
    ZDB-ID 134792-5
    ISSN 1432-1335 ; 0171-5216 ; 0084-5353 ; 0943-9382
    ISSN (online) 1432-1335
    ISSN 0171-5216 ; 0084-5353 ; 0943-9382
    DOI 10.1007/s00432-022-04171-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Loratidine is associated with improved prognosis and exerts antineoplastic effects via apoptotic and pyroptotic crosstalk in lung cancer.

    Liu, Xiwen / Zhong, Ran / Huang, Jiaxing / Chen, Zisheng / Xu, Haoxiang / Lin, Lixuan / Cai, Qi / He, Miao / Lao, Shen / Deng, Hongsheng / Li, Caichen / Li, Jianfu / Zheng, Yongmei / Liu, Xiaoyan / Zeng, Riqi / He, Jianxing / Liang, Wenhua

    Journal of experimental & clinical cancer research : CR

    2024  Volume 43, Issue 1, Page(s) 5

    Abstract: Background: Tumor-associated inflammation suggests that anti-inflammatory medication could be beneficial in cancer therapy. Loratadine, an antihistamine, has demonstrated improved survival in certain cancers. However, the anticancer mechanisms of ... ...

    Abstract Background: Tumor-associated inflammation suggests that anti-inflammatory medication could be beneficial in cancer therapy. Loratadine, an antihistamine, has demonstrated improved survival in certain cancers. However, the anticancer mechanisms of loratadine in lung cancer remain unclear.
    Objective: This study investigates the anticancer mechanisms of loratadine in lung cancer.
    Methods: A retrospective cohort of 4,522 lung cancer patients from 2006 to 2018 was analyzed to identify noncancer drug exposures associated with prognosis. Cellular experiments, animal models, and RNA-seq data analysis were employed to validate the findings and explore the antitumor effects of loratadine.
    Results: This retrospective study revealed a positive association between loratadine administration and ameliorated survival outcomes in lung cancer patients, exhibiting dose dependency. Rigorous in vitro and in vivo assays demonstrated that apoptosis induction and epithelial-mesenchymal transition (EMT) reduction were stimulated by moderate loratadine concentrations, whereas pyroptosis was triggered by elevated dosages. Intriguingly, loratadine was found to augment PPARγ levels, which acted as a gasdermin D transcription promoter and caspase-8 activation enhancer. Consequently, loratadine might incite a sophisticated interplay between apoptosis and pyroptosis, facilitated by the pivotal role of caspase-8.
    Conclusion: Loratadine use is linked to enhanced survival in lung cancer patients, potentially due to its role in modulating the interplay between apoptosis and pyroptosis via caspase-8.
    MeSH term(s) Animals ; Humans ; Lung Neoplasms/drug therapy ; Lung Neoplasms/genetics ; Lung Neoplasms/pathology ; Loratadine/pharmacology ; Loratadine/therapeutic use ; Retrospective Studies ; Caspase 8 ; Antineoplastic Agents/pharmacology ; Antineoplastic Agents/therapeutic use ; Apoptosis ; Prognosis
    Chemical Substances Loratadine (7AJO3BO7QN) ; Caspase 8 (EC 3.4.22.-) ; Antineoplastic Agents
    Language English
    Publishing date 2024-01-02
    Publishing country England
    Document type Journal Article
    ZDB-ID 803138-1
    ISSN 1756-9966 ; 0392-9078
    ISSN (online) 1756-9966
    ISSN 0392-9078
    DOI 10.1186/s13046-023-02914-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: The Relative Impact of Family History of Different Cancers on Lung Cancer Risk.

    Li, Jianfu / Li, Caichen / Cheng, Bo / He, Jianxing / Liang, Wenhua

    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

    2019  Volume 14, Issue 11, Page(s) e248–e249

    MeSH term(s) Humans ; Lung Neoplasms ; Risk Factors
    Language English
    Publishing date 2019-10-15
    Publishing country United States
    Document type Letter ; Comment
    ZDB-ID 2432037-7
    ISSN 1556-1380 ; 1556-0864
    ISSN (online) 1556-1380
    ISSN 1556-0864
    DOI 10.1016/j.jtho.2019.06.012
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Optimal Starting Age for Lung Cancer Screening With Low-Dose Computed Tomography: A Population Level Analysis.

    Li, Caichen / Liang, Hengrui / Zhong, Nanshan / He, Jianxing / Liang, Wenhua

    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

    2019  Volume 14, Issue 4, Page(s) e82–e84

    MeSH term(s) Early Detection of Cancer ; Humans ; Lung Neoplasms ; Radiation Dosage ; Smokers ; Tomography, X-Ray Computed
    Language English
    Publishing date 2019-03-29
    Publishing country United States
    Document type Letter ; Comment
    ZDB-ID 2432037-7
    ISSN 1556-1380 ; 1556-0864
    ISSN (online) 1556-1380
    ISSN 1556-0864
    DOI 10.1016/j.jtho.2018.12.008
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Impact of lymphadenectomy extent on immunotherapy efficacy in postresectional recurred non-small cell lung cancer: a multi-institutional retrospective cohort study.

    Deng, Hongsheng / Zhou, Juan / Chen, Hualin / Cai, Xiuyu / Zhong, Ran / Li, Feng / Cheng, Bo / Li, Caichen / Jia, Qingzhu / Zhou, Caicun / Petersen, René H / Rocco, Gaetano / Brunelli, Alex / Ng, Calvin S H / D'Amico, Thomas A / Su, Chunxia / He, Jianxing / Liang, Wenhua / Zhu, Bo

    International journal of surgery (London, England)

    2024  Volume 110, Issue 1, Page(s) 238–252

    Abstract: Background: Lymph node (LN) dissection is a common procedure for non-small cell lung cancer (NSCLC) to ascertain disease severity and treatment options. However, murine studies have indicated that excising tumor-draining LNs diminished immunotherapy ... ...

    Abstract Background: Lymph node (LN) dissection is a common procedure for non-small cell lung cancer (NSCLC) to ascertain disease severity and treatment options. However, murine studies have indicated that excising tumor-draining LNs diminished immunotherapy effectiveness, though its applicability to clinical patients remains uncertain. Hence, the authors aim to illustrate the immunological implications of LN dissection by analyzing the impact of dissected LN (DLN) count on immunotherapy efficacy, and to propose a novel 'immunotherapy-driven' LN dissection strategy.
    Materials and methods: The authors conducted a retrospective analysis of NSCLC patients underwent anti-PD-1 immunotherapy for recurrence between 2018 and 2020, assessing outcomes based on DLN count stratification.
    Results: A total of 144 patients were included, of whom 59 had a DLN count less than or equal to 16 (median, IQR: 11, 7-13); 66 had a DLN count greater than 16 (median, IQR: 23, 19-29). With a median follow-up time of 14.3 months (95% CI: 11.0-17.6), the overall median progression-free survival (PFS) was 7.9 (95% CI: 4.1-11.7) months, 11.7 (95% CI: 7.9-15.6) months in the combination therapy subgroup, and 4.8 (95% CI: 3.1-6.4) months in the immunotherapy alone subgroup, respectively. In multivariable Cox analysis, DLN count less than or equal to 16 is associated with an improved PFS in all cohorts [primary cohort: HR=0.26 (95% CI: 0.07-0.89), P =0.03]; [validation cohort: HR=0.46 (95% CI: 0.22-0.96), P =0.04]; [entire cohort: HR=0.53 (95% CI: 0.32-0.89), P =0.02]. The prognostic benefit of DLN count less than or equal to 16 was more significant in immunotherapy alone, no adjuvant treatment, pN1, female, and squamous carcinoma subgroups. A higher level of CD8+ central memory T cell (Tcm) within LNs was associated with improved PFS (HR: 0.235, 95% CI: 0.065-0.845, P =0.027).
    Conclusions: An elevated DLN count (cutoff: 16) was associated with poorer immunotherapy efficacy in recurrent NSCLC, especially pronounced in the immunotherapy alone subgroup. CD8+Tcm proportions in LNs may also impact immunotherapy efficacy. Therefore, for patients planned for adjuvant immunotherapy, a precise rather than expanded lymphadenectomy strategy to preserve immune-depending LNs is recommended.
    MeSH term(s) Humans ; Female ; Animals ; Mice ; Carcinoma, Non-Small-Cell Lung/surgery ; Lung Neoplasms/surgery ; Retrospective Studies ; Neoplasm Recurrence, Local/surgery ; Lymph Node Excision ; Immunotherapy
    Language English
    Publishing date 2024-01-01
    Publishing country United States
    Document type Multicenter Study ; Journal Article
    ZDB-ID 2212038-5
    ISSN 1743-9159 ; 1743-9191
    ISSN (online) 1743-9159
    ISSN 1743-9191
    DOI 10.1097/JS9.0000000000000774
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top